Alamar Biosciences counsel reports zero holdings

Alamar Biosciences’ General Counsel filed a Form 3 showing no reportable holdings or insider trades.

Rhea-AI Filing Summary

Alamar Biosciences, Inc. (ALMR) had its General Counsel, John L. Brottem, file an initial statement of beneficial ownership on Form 3. The filing reports no equity transactions and no reportable holdings of Alamar Biosciences securities by Brottem at the time of filing.

Key Figures

Reported buy transactions: 0 transactions Reported sell transactions: 0 transactions Reported holdings: 0 shares

3 metrics

Reported buy transactions 0 transactions Initial Form 3 for General Counsel John L. Brottem

Reported sell transactions 0 transactions Initial Form 3 for General Counsel John L. Brottem

Reported holdings 0 shares No holding entries or derivative positions reported

Key Terms

Form 3, beneficial ownership

2 terms

Form 3 regulatory

"file an initial statement of beneficial ownership on Form 3"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"file an initial statement of beneficial ownership on Form 3"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 3 for ALMR’s General Counsel report?

It reports that General Counsel John L. Brottem filed an initial statement of beneficial ownership and shows no reportable holdings or insider transactions in Alamar Biosciences, Inc. securities at the time of the filing.

Does the ALMR Form 3 show any insider purchases or sales?

No. The Form 3 reports no buy or sell transactions, and the transaction summary lists zero purchases, zero sales, and zero derivative exercises.

Who is the reporting person in this ALMR Form 3?

The reporting person is John L. Brottem, who is identified in the filing as an officer of Alamar Biosciences, Inc. with the title General Counsel.

Does this ALMR Form 3 indicate any Rule 10b5-1 trading plan?

No. The Form 3 data do not indicate any transactions and the Rule 10b5-1 plan status field is null, so there is no plan information reported in this filing.

Are there any derivative securities reported in the ALMR Form 3?

No. The derivative securities section is empty, and the derivative transaction and holding counts in the summary are zero, indicating no reportable options or other derivatives in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/16/2026 - 04:20 PM Accepted by SEC EDGAR 09/16/2026 - 04:19 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Brottem John L.

(Last) (First) (Middle)

C/O ALAMAR BIOSCIENCES, INC.

47071 BAYSIDE PARKWAY

(Street)

FREMONT CALIFORNIA 94538

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
09/14/2026

3. Issuer Name and Ticker or Trading Symbol
Alamar Biosciences, Inc. [ ALMR ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Timothy White, Attorney-in-Fact	09/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)